OMDAOmada Health, Inc.
Is the business good?
6 of 9 health tests passed. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is OMDA?
Omada Health, Inc. keeps −0.15% of every revenue dollar as operating profit, against 2.8% for the median Health Information Services name.
Operating margin · Health Information Services median 2.8% · 12 months to Q2 2026
- Share count, year on year
- +191%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 16%
R&D as % of revenue
- Gross margin
- 68%
Gross margin
| Year | Operating margin |
|---|---|
| FY2023 | −54% |
| FY2024 | −26% |
| FY2025 | −4.6% |
Details›
- Gross margin12 months to Q2 2026
- 68%
- Operating margin12 months to Q2 2026
- −0.15%
- Net margin12 months to Q2 2026
- 1.4%
- Free cash flow margin
- 7.3%
- R&D as % of revenue
- 16%
- Revenue, trailing twelve months
- $310M
- Free cash flow, trailing twelve months
- $23M
- Net income, trailing twelve months
- $4.3M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from OMDA and who it buys from, as the companies report it.
- Partner B33%
Share of revenue · FY2025 10-K
- Partner A32%
Share of revenue · FY2025 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; OMDA’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.
Health Information Services
The closest names by size in the same industry